ASTS three-lens brief
Evidence-based stock research on ASTS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 8.70% in the last session — a material single-day move. · Trading at 9% of its 52-week range — deep in the lower band.
- Price up 8.70% in the last session — a material single-day move.
- Trading at 9% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 37.4pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
ASTS closed at $36.62 (+8.70%) as of 2026-11-12. Market cap: $14.29B. Price is below the 50-day MA and below the 200-day MA. Positives: price up 8.70% in the last session — a material single-day move.; analyst mean target $66.18 — 81% above current (12 analysts).. Concerns: trading at 9% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $42.32M, net income -$132.38M, free cash flow -$1.89B.
Why three lenses on ASTS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASTS across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ASTS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASTS brief"></iframe>